Inflammatory bowel diseases (IBDs) are systemic diseases that manifest not only in the gut
and gastrointestinal tract, but also in the extraintestinal organs in many patients. The quality …

Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are frequent and
may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with …

The management of patients with IBD requires evaluation with objective tools, both at the
time of diagnosis and throughout the course of the disease, to determine the location …

Introduction: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily
of, but not restricted to the gut. Extraintestinal manifestations (EIMs) are frequently observed …

More than one-third of patients with IBD are affected by extraintestinal manifestations or
extraintestinal complications beyond the intestinal manifestation of the disease. The most …

Background & Aims Although the association between inflammatory bowel disease (IBD)
and primary sclerosing cholangitis (PSC) is well recognized, uncertainties remain about the …

Abstract Background and Aims: Extraintestinal manifestations [EIMs] are common in
inflammatory bowel disease [IBD]. Data on epidemiology and risk factors of EIMs in IBD …

Abnormal liver biochemical tests are present in up to 30% of patients with inflammatory
bowel disease (IBD), and therefore become a diagnostic challenge. Liver and biliary tract …

Background Extraintestinal manifestations are frequent in inflammatory bowel diseases
(IBD). Most studies published so far focused on viral hepatitis and liver toxicity of IBD‐related …

Background Evidence regarding all-cause and cause-specific mortality in inflammatory
bowel disease (IBD) is conflicting, and debate exists over appropriate study design to …